Relief Therapeutics Holding AG (RLFTF)

[go_wamu]

This is exactly the point I made in my previous posts. Zyesami is a very valuable and successful drug for the treatment of Covid19. But not only for Covid19, if you think on PAH, COPD, asthma and other lung diseases.
The clinical application of VIP is only possible by specialists and will be continuously improved. .... and that costs a lot of money and as you say rightly: the only way to obtain funds is to get the EUA.
But: "... the Tigers come at night" (from "Les Miserables").
IMO together with the FDA, BigPharma is waiting to swallow the goldfish. Will that work? I don't know, but Dr. JJ doesn't care! Its ultimate goal is not Covid19. Follow the video (from 44:41), then you know what's going on:

Quota:
".... the ability to get this drug to any hospital over night is impressing ....!"
".... wont need marketing and wont need to convince doctors"
".... the drug would speed pretty much!"
".... again, we will be announcing in the future a large partnership"
"....would there be a potential that the FDA would alow the EAP-Programm to be considered furthermore?"

And if it is not approved in the USA, then it will be sold worldwide. Thats the message!
Are you now selling your investment? I wouldn't do that!